<DOC>
	<DOCNO>NCT00259363</DOCNO>
	<brief_summary>- Phase I : To determine maximum tolerate dose , recommend dose propose dos oxaliplatin study - Phase II : To determine treatment efficacy accord response rate phase I .</brief_summary>
	<brief_title>Oxaliplatin Rectal Cancer</brief_title>
	<detailed_description />
	<mesh_term>Rectal Neoplasms</mesh_term>
	<mesh_term>Oxaliplatin</mesh_term>
	<criteria>The following information clinical trial provide information purpose allow patient physician initial discussion trial . This information intend complete information trial , contain consideration may relevant potential participation trial , replace advice personal physician health professional . Main criterion list hereafter : ECOG : 02 Histological prove rectal adenocarcinoma No chemotherapy treatment previous 6 month inclusion . No previous pelvic radiotherapy treatment Important Biological abnormality ( renal , hepatic and/or hematological ) Intestinal occlusion subocclusion Peripheral neuropathy Pregnant breastfeeding woman . Potential childbearing woman positive pregnancy test . Participation trial previous 4 month .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>December 2009</verification_date>
</DOC>